Alpha-MSH Depletion Causes Insatiable Appetite — Rescued by Melanotan II
Zebrafish genetically engineered to lack alpha-MSH developed insatiable appetite and weight gain, which was completely reversed by injection of Melanotan II — confirming alpha-MSH as a key appetite regulator and obesity target.
Quick Facts
What This Study Found
α-MSH mutant zebrafish showed hyperphagic phenotypes and weight gain with upregulated orexigenic genes (NPY, AgRP2, pmch, hcrt) and altered anorexigenic genes. Melanotan II injection completely rescued the hyperphagia, confirming α-MSH as a key appetite regulator.
Key Numbers
7aa and 8aa MSH deletions; hyperphagia + weight gain; 9 genes analyzed; Melanotan II fully rescued; altered energy expenditure
How They Did This
Genetic engineering of zebrafish α-MSH mutants (7aa and 8aa deletions) retaining other Pomc-derived peptides. Gene expression analysis of 9 appetite genes. Hindbrain ventricle injection of synthetic α-MSH analog and Melanotan II. Metabolic rate assessment by Alamar Blue assay.
Why This Research Matters
This proves α-MSH is a critical appetite suppressor, not just a correlate. The complete rescue by Melanotan II validates melanocortin receptor agonists as a legitimate approach to treating obesity — a billion-dollar pharmaceutical target.
The Bigger Picture
Melanocortin-based obesity drugs (like setmelanotide, approved for genetic obesity) work through the same pathway this study validates. Understanding α-MSH's specific role supports development of more targeted melanocortin therapies with fewer side effects.
What This Study Doesn't Tell Us
Zebrafish model — appetite regulation may differ from mammals. Hindbrain injection is not a practical delivery route. Melanotan II has side effects (skin darkening, nausea) that limit its clinical use. Long-term metabolic effects not assessed.
Questions This Raises
- ?Could more selective α-MSH analogs achieve appetite suppression without Melanotan II's side effects?
- ?Do the specific orexigenic gene changes match those seen in obese humans with melanocortin pathway defects?
- ?Would chronic Melanotan II administration maintain weight loss without tolerance developing?
Trust & Context
- Key Stat:
- Complete rescue by Melanotan II Insatiable appetite from α-MSH depletion was completely reversed by Melanotan II, proving this peptide pathway is necessary and sufficient for appetite control
- Evidence Grade:
- Moderate evidence: elegant genetic study with complete rescue experiment, but zebrafish model limits direct human translation.
- Study Age:
- Published 2021. Melanocortin-based obesity therapeutics continue advancing, with setmelanotide (Imcivree) approved for genetic obesity.
- Original Title:
- Depletion of Alpha-Melanocyte-Stimulating Hormone Induces Insatiable Appetite and Gains in Energy Reserves and Body Weight in Zebrafish.
- Published In:
- Biomedicines, 9(8) (2021)
- Database ID:
- RPEP-05451
Evidence Hierarchy
Frequently Asked Questions
What is alpha-MSH and how does it control appetite?
Alpha-MSH is a brain peptide that signals fullness and suppresses eating. When it's missing (as in this study), animals eat insatiably and gain weight. The same pathway is disrupted in some forms of human genetic obesity.
Is Melanotan II used for weight loss?
Melanotan II activated the α-MSH pathway and completely reversed overeating in this study. However, it's not approved for weight loss in humans due to side effects (skin darkening, nausea, blood pressure effects). A more selective drug, setmelanotide (Imcivree), is FDA-approved for specific genetic obesity conditions.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05451APA
Hsieh, Yang-Wen; Tsai, Yi-Wen; Lai, Hsin-Hung; Lai, Chi-Yu; Lin, Chiu-Ya; Her, Guor Mour. (2021). Depletion of Alpha-Melanocyte-Stimulating Hormone Induces Insatiable Appetite and Gains in Energy Reserves and Body Weight in Zebrafish.. Biomedicines, 9(8). https://doi.org/10.3390/biomedicines9080941
MLA
Hsieh, Yang-Wen, et al. "Depletion of Alpha-Melanocyte-Stimulating Hormone Induces Insatiable Appetite and Gains in Energy Reserves and Body Weight in Zebrafish.." Biomedicines, 2021. https://doi.org/10.3390/biomedicines9080941
RethinkPeptides
RethinkPeptides Research Database. "Depletion of Alpha-Melanocyte-Stimulating Hormone Induces In..." RPEP-05451. Retrieved from https://rethinkpeptides.com/research/hsieh-2021-depletion-of-alphamelanocytestimulating-hormone
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.